CCN2 and type 2 diabetes mellitus: Moreover, spironolactone treatment reduced urinary protein and albumin excretion and prohibited the glomerulosclerosis which correlated with reduction of CCN2, type I and type IV collagen expression in type 2 diabetes mellitus rat model (Figure 1) [46].